ReviewJournal of medical virology2021

Targeting the viral-entry facilitators of SARS-CoV-2 as a therapeutic strategy in COVID-19.

Shibi Muralidar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.